8CMU image
Entry Detail
PDB ID:
8CMU
EMDB ID:
Keywords:
Title:
High resolution structure of the coagulation Factor XIII A2B2 heterotetramer complex.
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2023-02-21
Release Date:
2024-09-11
Method Details:
Experimental Method:
Resolution:
2.41 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Coagulation factor XIII A chain
Chain IDs:A, B
Chain Length:732
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Coagulation factor XIII B chain
Chain IDs:C, D
Chain Length:661
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Cryo-EM structure of the human native plasma coagulation factor XIII complex.
Blood 145 438 449 (2025)
PMID: 39447073 DOI: 10.1182/blood.2024025369

Abstact

The structure of human coagulation factor XIII (FXIII), a heterotetrameric plasma protransglutaminase that covalently cross-links preformed fibrin polymers, remains elusive until today. The heterotetrameric complex is composed of 2 catalytic FXIII-A and 2 protective FXIII-B subunits. Structural etiology underlying FXIII deficiency has so far been derived from crystallographic structures, all of which are currently available for the FXIII-A2 homodimer only. Here, we present the cryogenic electron microscopy (cryo-EM) structure of a native, human plasma-derived FXIII-A2B2 complex at 2.4 Å resolution. The structure provides detailed information on FXIII subunit interacting interfaces as the 2 subunits interact strongly in plasma. The native FXIII-A2B2 complex reveals a pseudosymmetric heterotetramer of 2 FXIII-B monomers intercalating with a symmetric FXIII-A2 dimer forming a "crown"-like assembly. The symmetry axes of the A2 and B2 homodimers are twisted relative to each other such that Sushi domain 1 interacts with the catalytic core of the A subunit, and Sushi domain 2 with the symmetry related A' subunit, and vice versa. We also report 4 novel mutations in the F13A1 gene encoding the FXIII-A subunit from a cohort of patients with severe FXIII deficiency. Our structure reveals the etiological basis of homozygous and heterozygous pathogenic mutations and explains the conditional dominant negative effects of heterozygous mutations. This atomistic description of complex interfaces is consistent with previous biochemical data and shows a congruence between the structural biochemistry of the FXIII complex and the clinical features of FXIII deficiency.

Legend

Protein

Chemical

Disease

Primary Citation of related structures